Recently, Senators Chris Coons (D-DE), Orrin Hatch (R-UT), Amy Klobuchar (D-MN), and Marco Rubio (R-FL) introduced the Immigration Innovation Act of 2013, a measure that would raise the H-1B cap from the current 65,000 to 115,000 and even higher, under some circumstances. This would raise the current cap on the number of individuals eligible for H-1B visas issued annually to overseas professionals working for biopharmas and other U.S. tech employers. So, who’s actually doing the hiring?
You’ve already seen the top 10 biopharma layoffs of 2012; now, here are the top 10 biopharma companies with certified H-1B staff, ranked by their numbers of workers certified for employment through the H-1B visa program during federal Fiscal Year 2012, ending September 30, 2012. Also listed for companies are their numbers, if any, of workers denied the visas, and workers who were certified, but whose certifications were later withdrawn.